487 related articles for article (PubMed ID: 18634147)
1. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
[TBL] [Abstract][Full Text] [Related]
2. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
[TBL] [Abstract][Full Text] [Related]
4. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
5. Determinants of pulmonary arterial hypertension in scleroderma.
Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
[TBL] [Abstract][Full Text] [Related]
6. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
Kayikçioğlu M; Kültürsay H
Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
[TBL] [Abstract][Full Text] [Related]
7. Can we predict the severity of pulmonary hypertension in patients with scleroderma?
Acosta Colmán MI; Avila Pedretti G; Acosta ME; Simeón Aznar CP; Fonollosa Plá V; Villardel Torrés M
Reumatol Clin; 2012; 8(5):259-62. PubMed ID: 22658662
[TBL] [Abstract][Full Text] [Related]
8. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
[TBL] [Abstract][Full Text] [Related]
9. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
Mok MY; Cheung BM; Lo Y; Leung RY; Wong WS; Lau CS
J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
[TBL] [Abstract][Full Text] [Related]
12. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.
Prabu A; Patel K; Yee CS; Nightingale P; Situnayake RD; Thickett DR; Townend JN; Gordon C
Rheumatology (Oxford); 2009 Dec; 48(12):1506-11. PubMed ID: 19671698
[TBL] [Abstract][Full Text] [Related]
14. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.
Steen V; Chou M; Shanmugam V; Mathias M; Kuru T; Morrissey R
Chest; 2008 Jul; 134(1):146-51. PubMed ID: 18403670
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcome in systemic sclerosis.
Voilliot D; Magne J; Dulgheru R; Kou S; Henri C; Caballero L; De Sousa C; Sprynger M; Andre B; Pierard LA; Lancellotti P
Acta Cardiol; 2015 Oct; 70(5):554-63. PubMed ID: 26567815
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection of early pulmonary vascular dysfunction in scleroderma.
Reichenberger F; Voswinckel R; Schulz R; Mensch O; Ghofrani HA; Olschewski H; Seeger W
Respir Med; 2009 Nov; 103(11):1713-8. PubMed ID: 19497725
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide in systemic sclerosis: new insights.
Elshamy HA; Ibrahim SE; Farouk HM; Moustafa AA; Aly IM; Osman WM
Eur J Dermatol; 2011; 21(5):686-90. PubMed ID: 21700537
[TBL] [Abstract][Full Text] [Related]
20. Exercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review.
Baptista R; Serra S; Martins R; Teixeira R; Castro G; Salvador MJ; Pereira da Silva JA; Santos L; Monteiro P; Pêgo M
Arthritis Res Ther; 2016 Jul; 18(1):153. PubMed ID: 27368695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]